Sunshine Biopharma Statistics
Total Valuation
SBFM has a market cap or net worth of $2.57 million. The enterprise value is -$3.67 million.
| Market Cap | 2.57M |
| Enterprise Value | -3.67M |
Important Dates
The next estimated earnings date is Wednesday, August 19, 2026, after market close.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SBFM has 2.12 million shares outstanding. The number of shares has increased by 286.75% in one year.
| Current Share Class | 2.12M |
| Shares Outstanding | 2.12M |
| Shares Change (YoY) | +286.75% |
| Shares Change (QoQ) | +1.10% |
| Owned by Insiders (%) | 0.48% |
| Owned by Institutions (%) | 9.59% |
| Float | 2.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.07 |
| Forward PS | 0.09 |
| PB Ratio | 0.03 |
| P/TBV Ratio | 0.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.22 |
| Quick Ratio | 1.87 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -27.32% and return on invested capital (ROIC) is -12.47%.
| Return on Equity (ROE) | -27.32% |
| Return on Assets (ROA) | -10.02% |
| Return on Invested Capital (ROIC) | -12.47% |
| Return on Capital Employed (ROCE) | -29.45% |
| Weighted Average Cost of Capital (WACC) | 8.89% |
| Revenue Per Employee | $709,866 |
| Profits Per Employee | -$120,789 |
| Employee Count | 50 |
| Asset Turnover | 1.24 |
| Inventory Turnover | 1.90 |
Taxes
In the past 12 months, SBFM has paid $61,770 in taxes.
| Income Tax | 61,770 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.54% in the last 52 weeks. The beta is 1.31, so SBFM's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | -91.54% |
| 50-Day Moving Average | 1.89 |
| 200-Day Moving Average | 9.40 |
| Relative Strength Index (RSI) | 29.16 |
| Average Volume (20 Days) | 835,246 |
Short Selling Information
The latest short interest is 62,455, so 2.94% of the outstanding shares have been sold short.
| Short Interest | 62,455 |
| Short Previous Month | 113,463 |
| Short % of Shares Out | 2.94% |
| Short % of Float | 2.96% |
| Short Ratio (days to cover) | 0.69 |
Income Statement
In the last 12 months, SBFM had revenue of $35.49 million and -$6.04 million in losses. Loss per share was -$12.83.
| Revenue | 35.49M |
| Gross Profit | 11.71M |
| Operating Income | -4.58M |
| Pretax Income | -5.98M |
| Net Income | -6.04M |
| EBITDA | -6.15M |
| EBIT | -6.50M |
| Loss Per Share | -$12.83 |
Balance Sheet
The company has $6.98 million in cash and $744,840 in debt, with a net cash position of $6.24 million or $2.94 per share.
| Cash & Cash Equivalents | 6.98M |
| Total Debt | 744,840 |
| Net Cash | 6.24M |
| Net Cash Per Share | $2.94 |
| Equity (Book Value) | 21.52M |
| Book Value Per Share | 43.83 |
| Working Capital | 18.91M |
Cash Flow
In the last 12 months, operating cash flow was -$5.71 million and capital expenditures -$172,130, giving a free cash flow of -$5.88 million.
| Operating Cash Flow | -5.71M |
| Capital Expenditures | -172,130 |
| Depreciation & Amortization | 344,136 |
| Net Borrowing | n/a |
| Free Cash Flow | -5.88M |
| FCF Per Share | -$2.77 |
Margins
Gross margin is 32.98%, with operating and profit margins of -12.90% and -17.02%.
| Gross Margin | 32.98% |
| Operating Margin | -12.90% |
| Pretax Margin | -16.84% |
| Profit Margin | -17.02% |
| EBITDA Margin | -17.33% |
| EBIT Margin | -18.30% |
| FCF Margin | n/a |
Dividends & Yields
SBFM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -286.75% |
| Shareholder Yield | -286.75% |
| Earnings Yield | -234.07% |
| FCF Yield | -227.90% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 1, 2026. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 1, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
SBFM has an Altman Z-Score of -1.67 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.67 |
| Piotroski F-Score | 3 |